Do not freeze or expose to excessive heat
Phases 2 and 3 No timescale has yet been set for Phase 2 or 3 implementation across Scotland, which will allow prescribing in those with BMI 35 kg/m 2 (32 kg/m 2 in ethnic groups) and BMI 30 kg/m 2 (27 kg/m 2 in ethnic groups), respectively, alongside one or more obesity-related clinical condition
Key Takeaway: The main interaction risk is delayed gastric emptying, which can alter the timing and consistency of how oral blood thinners are absorbed by your body
Some of the key responses that are triggered include: Increased insulin Trusted Source Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial Kapitza C, Dahl K, Jacobsen JB, Axelsen MB, Flint A Go to Source secretion, so that glucose from food gets burned for energy instead of stored as fat Slowed gastric emptying Increased satiety Reduces cravings for sweet and fatty foods Weight loss Together, these biological responses contribute to the effectiveness of GLP-1 in promoting weight loss and improving blood sugar regulation in individuals with type 2 diabetes or those with obesity
